LoginSignup
Merck & Co logo

Merck & Co

Stock
Stock
ISIN: US58933Y1055
Ticker: MRK
US58933Y1055
MRK

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Merck & Co has so far distributed $0.81 in 2025. The next dividend will be paid on 07.04.2025

$1.445

CHART BY

Frequently asked questions

What is Merck & Co's market capitalization?

The market capitalization of Merck & Co is $221.80B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Merck & Co's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Merck & Co is 13.02. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Merck & Co?

Merck & Co's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $6.734. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Merck & Co's stock?

Currently, 27 analysts cover Merck & Co's stock, with a consensus target price of $115.71. Analyst ratings provide insights into the stock's expected performance.

What is Merck & Co's revenue over the trailing twelve months?

Over the trailing twelve months, Merck & Co reported a revenue of $64.30B.

Is Merck & Co paying dividends?

Yes, Merck & Co is paying dividends. The next payment is scheduled for 07.04.2025, with an expected amount of .

What is the free float of Merck & Co's shares?

The free float of Merck & Co is 2.53B. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$221.80B
EPS (TTM) 
$6.734
Free Float 
2.53B
P/E ratio (TTM) 
13.02
Revenue (TTM) 
$64.30B

Pricing

1D span
$87.06$89.50
52W span
$81.20$134.61

Analyst Ratings

The price target is $115.71 and the stock is covered by 27 analysts.

Buy

17

Hold

10

Sell

0

Information

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Industries
Major Pharmaceuticals
Sector
Health Care

Identifier

ISIN
US58933Y1055
Primary Ticker
MRK

Knockouts

Finance data from FactSet
Join the conversation
Sign upLogin